Crossmark

A bioanalytically validated RP-HPLC method for simultaneous quantification of rivaroxaban, paracetamol, and ceftriaxone in human plasma: a combination used for COVID-19 management

Crossref DOI link: https://doi.org/10.1038/s41598-024-75729-y

Published Online: 2024-10-28

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ismail, Reham A.

Ayad, Miriam F.

Hussein, Lobna A.

Trabik, Yossra A.
Funding

Funding for this research was provided by:

Ain Shams University
License Information

Text and Data Mining valid from 2024-10-28

Version of Record valid from 2024-10-28
More Information

Article History

Received: 26 April 2024

Accepted: 8 October 2024

First Online: 28 October 2024

Declarations

:

: The authors declare no competing interests.

Document is current

Any future updates will be listed below